{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:43:04Z","timestamp":1770896584050,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["93034823"],"award-info":[{"award-number":["93034823"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.07.033","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T07:49:44Z","timestamp":1532159384000},"page":"5124-5132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection"],"prefix":"10.1016","volume":"36","author":[{"given":"Amir","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazanin","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrnaz","family":"Taghipour Karsabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Amani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolfazl","family":"Ardjmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zarichehr","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.033_b0005","doi-asserted-by":"crossref","first-page":"11939","DOI":"10.3748\/wjg.v20.i34.11939","article-title":"Helicobacter pylori vaccination: Is there a path to protection","volume":"34","author":"Anderl","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/infdis\/161.4.626","article-title":"Helicobacter pylori and the pathogenesis of gastroduodenal inflammation","volume":"161","author":"Blaser","year":"1990","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.07.033_b0015","article-title":"Helicobacter pylori, gastric cancer and other gastrointestinal malignancies","volume":"22","author":"Venerito","year":"2017","journal-title":"Helicobacter"},{"key":"10.1016\/j.vaccine.2018.07.033_b0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcmgh.2016.12.001","article-title":"The clinical evidence linking helicobacter pylori to gastric cancer","volume":"3","author":"Moss","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40364-017-0103-x","article-title":"Update on the first-line treatment for Helicobacter pylori infection \u2013 a continuing challenge from an old enemy","volume":"5","author":"Huang","year":"2017","journal-title":"Biomarker Res"},{"key":"10.1016\/j.vaccine.2018.07.033_b0030","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","article-title":"Helicobacter pylori infection","volume":"362","author":"McColl","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.07.033_b0035","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.3748\/wjg.v22.i11.3150","article-title":"Vaccine against Helicobacter pylori: inevitable approach","volume":"22","author":"Abadi","year":"2016","journal-title":"World J Gastroenterol: WJG"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2018.07.033_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/hel.12336","article-title":"Inflammation, immunity, and vaccines for Helicobacter pylori infection","volume":"21","author":"Velin","year":"2016","journal-title":"Helicobacter."},{"key":"10.1016\/j.vaccine.2018.07.033_b0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/egh.10.6","article-title":"Advances in vaccination against Helicobacter pylori","volume":"4","author":"Velin","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0050","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1365-2036.2005.02408.x","article-title":"Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome","volume":"21","author":"Wheeldon","year":"2005","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.vaccine.2018.07.033_b0055","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1128\/iai.65.11.4668-4674.1997","article-title":"Catalase, a novel antigen for Helicobacter pylori vaccination","volume":"65","author":"Radcliff","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.07.033_b0060","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1016\/j.vaccine.2012.06.052","article-title":"Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice","volume":"30","author":"Chen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0065","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.vaccine.2014.02.051","article-title":"Heat shock protein complex vaccination induces protection against Helicobacter pylori without exogenous adjuvant","volume":"32","author":"Chionh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0070","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1073\/pnas.92.14.6499","article-title":"The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice","volume":"92","author":"Ferrero","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2018.07.033_b0075","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1128\/iai.65.12.4996-5002.1997","article-title":"Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection","volume":"65","author":"Ghiara","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.07.033_b0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrgastro.2011.1","article-title":"Vaccinating against Helicobacter pylori infection","volume":"8","author":"Czinn","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0085","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.191.9.1467","article-title":"The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor","volume":"191","author":"Satin","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.07.033_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.2006.00206.x","article-title":"Effectiveness of vaccinationwith recombinant HpaA from Helicobacter pylori is influenced by host genetic background","volume":"50","author":"Sutton","year":"2007","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0095","first-page":"411","article-title":"Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit","volume":"18","author":"Yang","year":"2005","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/j.vaccine.2018.07.033_b0100","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1016\/j.vaccine.2011.06.099","article-title":"Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0105","doi-asserted-by":"crossref","first-page":"e0130391","DOI":"10.1371\/journal.pone.0130391","article-title":"Immunization with heat shock protein A and gamma-glutamyl transpeptidase induces reduction on the Helicobacter pylori colonization in mice","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.07.033_b0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.vaccine.2012.10.091","article-title":"Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice","volume":"31","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0115","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1016\/j.vaccine.2014.07.041","article-title":"Therapeutic efficacy of the multi-epitope vaccine CTB-UE against Helicobacter pylori infection in a Mongolian gerbil model and its microRNA-155-associated immuno-protective mechanism","volume":"32","author":"Lv","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1874285801610010097","article-title":"In silico design of a chimeric protein containing antigenic fragments of Helicobacter pylori; a bioinformatic approach","volume":"10","author":"Mohammad","year":"2016","journal-title":"Open Microbiol J"},{"key":"10.1016\/j.vaccine.2018.07.033_b0125","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.molimm.2018.01.001","article-title":"Immunization with recombinant FliD confers protection against Helicobacter pylori infection in mice","volume":"94","author":"Ghasemi","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.vaccine.2012.12.058","article-title":"Identification of two novel immunodominant UreB CD4+ T cell epitopes in Helicobacter pylori infected subjects","volume":"31","author":"Yang","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0135","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1128\/IAI.69.11.6597-6603.2001","article-title":"Identification of an antigenic epitope inHelicobacter pylori urease that induces neutralizing antibody production","volume":"69","author":"Hirota","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.07.033_b0140","doi-asserted-by":"crossref","first-page":"10570","DOI":"10.1016\/S0021-9258(19)50054-0","article-title":"Purification and characterization of the vacuolating toxin from Helicobacter pylori","volume":"267","author":"Cover","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.07.033_b0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fcimb.2012.00070","article-title":"An RGD helper sequence in CagL of Helicobacter pylori assists in interactions with integrins and injection of CagA","volume":"2","author":"Conradi","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0150","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.vaccine.2014.09.013","article-title":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection","volume":"32","author":"Ghasemi","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0155","doi-asserted-by":"crossref","first-page":"e6875","DOI":"10.5812\/jjm.6875","article-title":"Optimization and efficient purification in production of Brucella melitensis recombinant HSP A and TF proteins with low endotoxin contents","volume":"6","author":"Ghasemi","year":"2013","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0076-6879(90)82008-P","article-title":"Quantitation of protein","volume":"182","author":"Stoscheck","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0165","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1016\/j.vaccine.2015.09.013","article-title":"Simultaneous immunization of mice with Omp31 and TF provides protection against Brucella melitensis infection","volume":"33","author":"Ghasemi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0170","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1007\/s00253-015-6705-z","article-title":"A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB\/c mouse model","volume":"99","author":"Song","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice","volume":"62","author":"Ghasemi","year":"2014","journal-title":"Mol Immunol"},{"issue":"2237\u201346","key":"10.1016\/j.vaccine.2018.07.033_b0180","article-title":"Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model","volume":"136","author":"Velin","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2018.07.033_b0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.07.033_b0190","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/vaccines3030579","article-title":"Cholera toxin subunit B as adjuvant\u2013an accelerator in protective immunity and a break in autoimmunity","volume":"3","author":"Stratmann","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2018.07.033_b0195","doi-asserted-by":"crossref","first-page":"e0169501","DOI":"10.1371\/journal.pone.0169501","article-title":"Intranasal immunization using mannatide as a novel adjuvant for an inactivated influenza vaccine and its adjuvant effect compared with MF59","volume":"12","author":"Ren","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2018.07.033_b0200","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2013.05.007","article-title":"The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect","volume":"31","author":"Calabro","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0205","article-title":"The influence of adjuvant on UreB protection against Helicobacter pylori through the diversity of CD4+ T-cell epitope repertoire","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.vaccine.2018.07.033_b0210","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.vaccine.2010.12.019","article-title":"Evaluation of superoxide dismutase from Helicobacter pylori as a protective vaccine antigen","volume":"29","author":"Every","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0215","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1016\/j.vaccine.2008.05.004","article-title":"Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori","volume":"26","author":"Skene","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0220","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.vaccine.2003.11.035","article-title":"Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy","volume":"22","author":"Blanchard","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0225","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1211\/0022357022269","article-title":"Effect of methotrexate on Th1 and Th2 immune responses in mice","volume":"55","author":"Yamaki","year":"2003","journal-title":"J Pharmacy Pharmacol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0230","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2014.09.014","article-title":"Helicobacter pylori outer inflammatory protein DNA vaccine-loaded bacterial ghost enhances immune protective efficacy in C57BL\/6 mice","volume":"32","author":"Chen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.033_b0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Martin","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2018.07.033_b0240","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1440-1711.2001.01039.x","article-title":"A locus affecting immunoglobulin isotype selection (Igis1) maps to the MHC region in C57BL, BALB\/c and NOD mice","volume":"79","author":"Matthews","year":"2001","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: a novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.07.033_b0250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3347\/kjp.2006.44.1.43","article-title":"Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice","volume":"44","author":"Mohammadi","year":"2006","journal-title":"Korean J Parasitol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0255","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12223","article-title":"Identification of immunodominant Leishmania major antigenic markers of the early C57BL\/6 and BALB\/c mice infection stages","author":"Sassi","year":"2015","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0260","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00016350152509238","article-title":"T-cell-mediated mucosal immunity in the absence of antibody: lessons from Helicobacter pylori infection","volume":"59","author":"Ernst","year":"2001","journal-title":"Acta Odontol Scand"},{"key":"10.1016\/j.vaccine.2018.07.033_b0265","doi-asserted-by":"crossref","first-page":"e69384","DOI":"10.1371\/journal.pone.0069384","article-title":"Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization","volume":"8","author":"Ding","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2018.07.033_b0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2007.06.006","article-title":"Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice","volume":"44","author":"Taylor","year":"2008","journal-title":"Microb Pathogen"},{"key":"10.1016\/j.vaccine.2018.07.033_b0275","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0016-5085(97)70004-0","article-title":"Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load","volume":"113","author":"Mohammadi","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2018.07.033_b0280","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.07.033_b0285","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.coi.2013.03.011","article-title":"Th17 cell based vaccines in mucosal immunity","volume":"25","author":"Kumar","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0290","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4049\/jimmunol.170.4.1958","article-title":"CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism","volume":"170","author":"Chung","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0295","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.0901115","article-title":"Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice","volume":"184","author":"Shi","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.033_b0300","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.gastro.2008.09.017","article-title":"Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent","volume":"136","author":"DeLyria","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2018.07.033_b0305","doi-asserted-by":"crossref","first-page":"40","DOI":"10.11606\/S1518-8787.2018052000384","article-title":"Adverse events of vaccines and the consequences of non-vaccination: a critical review","volume":"52","author":"Aps","year":"2018","journal-title":"Rev Saude Publica."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:04Z","timestamp":1759400884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18310028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":61,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18310028"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with a recombinant fusion protein protects mice against Helicobacter pylori infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}